Facebook Pixel

AUDIO: Dr. Jill Siegfried - Is Lung Cancer More Fatal In HRT Recipients?

By Expert
Rate This

According to a study published in the journal “Lancet,” the “Los Angeles Times” reports women who take hormone replacement therapy are nearly twice as likely to die from lung cancer.

Hi, this is Todd Hartley, and to bring you up to speed on this developing news EmpowHer, the home of women’s health online, is going to connect you right now with Dr. Jill Siegfried, a professor and Chair of the Lung Cancer Research at the University of Pittsburgh’s Department of Pharmacology and Chemical Biology. Hi, Dr. Siegfried.

Dr. Jill Siegfried:

Dr. Siegfried, the findings, the findings show that women on HRT, otherwise known as hormone replacement therapy, are no more likely to develop lung cancer, but if they do they are more likely to die. Is that accurate?

Dr. Jill Siegfried:
Yes. Statistically there was a much higher mortality from lung cancer in the hormone replacement arm of the study. There was actually an increase also in lung tumors in the HRT arm.

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Lung Cancer

Get Email Updates

Lung Cancer Guide

Have a question? We're here to help. Ask the Community.


Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!